Skip to main content

Personal Protective Equipment


We have an opportunity to improve the short term and long term approach to Personal Protective Equipment (PPE) worldwide. We can best meet this opportunity by respecting one another’s place and space.

We should:
  • Initiate international, regional and local discussions around PPE needs. Ask countries what the want and need, and set intentions for standardization with genuine partnership.
  • Catalog the regulatory agencies involved with PPE by country.
  • Detail the manufacturing supply chain by country. Detail the current processes, time and transport logistics. List and compare product safety processes involved, including failures and breaches noted. If 60% of the PPE manufacturing is based in two countries, what is the being asked of the rest of the world? What are populations awaiting, what are the logistics issues, what are the regulatory and product safety differences between countries and how are these populations affected? Are comparisons even offered before procurement? 
  • Develop surveillance and data around PPE use. Have countries’ product safety and regulatory differences mattered when examining healthcare-acquired or workplace transmission of COVID or other pathogens? Is the same HAI and/or workplace surveillance conducted in a country with multi-manufacturer use? 
  • Detail a research and development plan that is inclusive of LMIC at all stages of research.
  • Initiate a global plan to address the recommendations, with indicators and timelines structured to recent reports.
      
            1. The five main recommendations should be a global movement. They include: 

            

            *Assembling PPE innovation

            *Improving PPE standards and quality

            *Expanding PPE manufacturing capabilities

            *Strengthening procurement practices

            *Improving usage and disposal


    2. Five recommendations for sector focus on PPE improvements include: 


*Government. Government can support and steer the establishment of at-scale regional manufacturing, supplement national preparedness stocks of PPE, and move beyond lowest-price to encourage the development of high quality and innovative PPE. We should partner with governments when welcomed. 


*World Health. World health and WHO should add the key element of ‘access to PPE’ in preparedness frameworks. Regulators and standards organisations should be convened to harmonie medical PPE standards, and target product characteristics for PPE should be set for innovative design. World health can gently steer countries forward with preparedness in mind, emphasizing preparedness for each country. 


*Philanthropic and nonprofit funding. Funders should develop and enforce ‘pull’ and ‘push’ incentives for innovation by establishing visibility mechanisms for HCW in need and visibility on PPE innovation. Funders should take care to ask populations and countries what innovations are a fit, as well.


*Financial institutions. Development banks and finance institutions can support local manufacturing and testing capacity by financing solutions and guidance. Development banks should invest in PPE,  the development of national procurement processes, quality assurance mechanisms and last mile delivery systems. 
 
*Manufacturers. Manufacturers need to engage with governments, stakeholders, innovators that meet affordability, safety and quality for healthcare. 


Rather than reinvent the wheel, we can develop a strong PPE system with expertise already at the table. And, we can do so with vested country leadership. With healthcare first in mind, the structure of PPE improvements will be set for all industries requiring personal protection on the job. 


A solid, predictable, sustainable, science-based PPE system should be prioritized, and it should be prioritized when welcomed into a country’s place and space.

Comments

Post a Comment

Popular posts from this blog

Oxygen

Keeping it simple for oxygen coordination is best accomplished when we're welcomed in.  It’s good to support global leadership in medical oxygen supply management for underserved communities and countries in need.  It’s great to support efforts that strengthen individual country leadership toward national strategies on medical oxygen supply management.   Both require some tread into a country’s vulnerabilities on medical needs.  Let’s tread meaningfully and in a way that assures a welcome back.  Detail the coordinating agencies or government departments responsible for medical oxygen supply receipt. Meet with health administrators.  Detail a country’s current policies, compare with a global review and detail opportunities for policies on oxygen management. Is medical oxygen supply and/or maintenance an ongoing regulatory component within a country? What would it take to sharpen regulatory efforts? Is medical oxygen supply a component to ongoing emergen...
Post a Comment
Read more

Vaccination

 Meet people where they are.  Immunization is a cornerstone of public health and vaccination is an investment for the individual.  The cornerstone is fractured when there is incongruence between medicine and public health.  The investment is fractured when there is a disconnect between the individual and the public. Repair the fractured cornerstone. Be professional with the professional credentials handed. In a functioning, interdependent system, we would rely on scientific expertise for research and development of a tool, we would rely on medical expertise and diagnosticians to assess appropriateness of this tool to the individual, and we would rely on public health experts to bring the tool to people - where they are. We do not have a functioning, interdependent system in a world of discourse and inconsistent application of scientific concepts. While we cannot control the external energy, we can control how we meet people where they are.  We should set expecta...
Post a Comment
Read more

Experts and Regulation

For all the global health coordination, and all the international research collaboration, there is no movement toward scope of practice, labor regulation, prescribing regulation or biotechnological responsibility standardization.  We should encourage measured progress toward accountability in medicine regulation, and we should do so with countries at the table.   What are the medical professions, credentials, approved education and scope of practice in healthcare, per country? What are the community healthcare worker (CHW) roles if allowed, per country? What would countries like to see adjusted or mirrored?  Which procedures are allowed for each healthcare profession? What are the rationales, inclusive of supply and demand and access issues?  What are the differences in approvals and guidelines for medicine safety, and for who can prescribe what? What is the healthcare political climate in various countries and how does this affect decision making? What analytic...
Post a Comment
Read more